Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naive HIV-1 infected adults

Ho, S; Wong, JG; Ng, OT; Lee, CC; Leo, YS; Lye, DCB; Wong, CS

Wong, CS (corresponding author), Natl Ctr Infect Dis, Singapore, Singapore.

AIDS RESEARCH AND THERAPY, 2020; 17 (1):

Abstract

Background The anti-retroviral combination of abacavir/lamivudine plus rilpivirine (ABC/3TC/RPV) is not recommended by international guidelines as the......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索